PARSHALL B LYNNE - Insider Non-Derivative Transactions at IONIS PHARMACEUTICALS INC (IONS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 15, 2024, PARSHALL B LYNNE's relationship to IONIS PHARMACEUTICALS INC (IONS) is Director, and currently has 87,265 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other IONS insiders.

Data Source: SEC.
PARSHALL B LYNNE - Insider Non-Derivative Transactions of IONS Common Stock
PARSHALL B LYNNE - Insider Non-Derivative Transactions at IONS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 16, 2024 M -- (Common Stock) 4677 0 87265
Dec 29, 2023 Sell -- (Common Stock) 42525 50.19 82588
Dec 29, 2023 M -- (Common Stock) 42525 47.34 125113
Dec 28, 2023 Sell -- (Common Stock) 50000 50.23 82588
Dec 28, 2023 M -- (Common Stock) 50000 47.34 132588
Dec 27, 2023 Sell -- (Common Stock) 25113 51.46 82588
Dec 27, 2023 M -- (Common Stock) 25113 47.34 107701
Sep 27, 2023 Sell -- (Common Stock) 10000 45.13 82588
Jul 18, 2023 M -- (Common Stock) 1777 0 87255
Jul 18, 2023 M -- (Common Stock) 5333 0 92588